MedTrace Logo

TOTEM: Trial of TAP Block Effective Medications

NCT04382859 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2020-11-27

No results posted yet for this study

Summary

Our goal is to determine if liposomal bupivacaine compared to standard bupivacaine results in increased pain control and decreased narcotic pain medication use when used in TAP blocks prior to laparoscopic hysterectomies for benign indications.

Conditions

  • Pain, Postoperative

Interventions

PROCEDURE

Transversus abdominis plane (TAP) block with liposomal bupivacaine

Transversus abdominis plane (TAP) blocks are safe and effective procedures for the provision of postoperative pain management following abdominal procedures (3) and have been widely used across specialties with reduction in postoperative pain and narcotic use (4-7).

Sponsors & Collaborators

  • Western Michigan University School of Medicine

    lead OTHER

Principal Investigators

  • Melinda Abernethy, MD · Western Michigan University Homer Stryker M.D. School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2020-12-31
Completion
2021-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04382859 on ClinicalTrials.gov